PIK3CA and hepatocellular carcinoma: Hepatoma exhibits the highest percentage of PIK3ca (p110 catalytic subunit of PI3-K) mutations (36%) among solid tumors, and sustained Akt activation leads to deleterious cell survival and chemo-resistance in HCC cells [26].